(Q35187838)

7 August 2017

1 reference

title

Ethical considerations for pharmacogenomic testing in pediatric clinical care and research (English)

1 reference

7 August 2017

0 references

1 reference

1 reference

Cassandra Moran

1

1 reference

7 August 2017

Courtney D Thornburg

series ordinal

2

1 reference

7 August 2017

Raymond C Barfield

series ordinal

3

1 reference

7 August 2017

publication date

1 June 2011

1 reference

7 August 2017

1 reference

7 August 2017

volume

12

1 reference

7 August 2017

issue

6

1 reference

7 August 2017

page(s)

889-895

1 reference

Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science.

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Views of discrimination among individuals confronting genetic disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Pharmacogenetics of intestinal absorption.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

The genetics revolution and primary care pediatrics

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Clinical pharmacogenetics in pediatric patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Should pharmacogenomic studies be required for new drug approval?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Disclosing individual genetic results to research participants

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

A lay prescription for tailor-made drugs--focus group reflections on pharmacogenomics.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Informed lay preferences for delivery of racially varied pharmacogenomics

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Attitudinal barriers to delivery of race-targeted pharmacogenomics among informed lay persons

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Developmental pharmacology--drug disposition, action, and therapy in infants and children

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Pharmacogenomics--drug disposition, drug targets, and side effects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Informed consent for treatment of childhood cancer: factors affecting parents' decision making

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Testing medications in children.

28 July 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.216

Frequency and development of CNS involvement in Chinese children with hemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.216

Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.216

In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.216

Evaluating direct-to-consumer marketing of race-based pharmacogenomics: a focus group study of public understandings of applied genomic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.216

How will GINA influence participation in pharmacogenomics research and clinical testing?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.216

The FDA announces new drug labeling for pharmacogenetic testing: is personalized medicine becoming a reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.216

Delivery of genomic medicine for common chronic adult diseases: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.216

Thresholds and boundaries in the disclosure of individual genetic research results.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.216

Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Direct-to-consumer genome scanning services. Also for children?

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Pharmacogenetic testing: not as simple as it seems

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164260

Unlicensed and off-label drug use in children: implications for safety

27 September 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.216

Pharmacogenomic variations in treatment protocols for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

12 December 2020

Unlicensed and off-label drug use in children: implications for safety

1 reference

12 December 2020

Pharmacogenetic testing, informed consent and the problem of secondary information

1 reference

12 December 2020

[Pharmacogenetics in future medical care -- implications for patients and physicians]

1 reference

12 December 2020

Identifiers

DOI

10.2217/PGS.10.216

1 reference

7 August 2017

1 reference

7 August 2017

1 reference